Biotech Startups

1 investor

Pyrojas develops whole-cell cancer vaccines engineered from patients' own tumors to activate T cell responses against multiple antigens. The company focuses on precision immunotherapy for cancer treatment.

1 investor

QCDx develops liquid biopsy technologies using live 3D imaging to detect and profile circulating tumor cells for cancer diagnosis and drug development. The RareScope platform enables oncologists to optimize treatment strategies and therapeutic agents through single-cell phenotypic analysis of rare cancer cells in early-stage and advanced disease.

1 investor

QED Science develops AI tools designed to assist human scientists in their research rather than replace them, trained on feedback from thousands of domain experts including Nobel laureates. It serves scientists and research organizations, with offerings aimed at pharma, biotech, and life science organizations.

1 investor

Qlaris Bio is a clinical-stage biotechnology company developing therapies for ophthalmology conditions. Its lead candidate, QLS-111, is a topical eye-drop treatment for glaucoma that lowers intraocular pressure by targeting episcleral venous pressure.

1 investor

Qlucore develops software for exploring and analyzing high-dimensional biological data, including gene expression and next-generation sequencing data, through interactive 3D visualization and machine learning. Founded out of Lund University research, it also offers a platform for multi-omics companion and precision diagnostics aimed at precision oncology and clinical use.

1 investor

QNTM Labs is a GMP-certified contract laboratory providing quality control testing and chemical analysis services for pharmaceutical companies, with particular expertise in small molecule drugs. The company offers outsourced QC activities, analytical method development, stability studies, and trace element analysis to help pharmaceutical manufacturers meet regulatory compliance and quality standards.

1 investor

Qorium develops cell-cultured leather grown from a single animal cell sample, producing uniform collagen sheets that integrate into existing tannery and leather-goods production processes. It partners with tanneries and global brands to supply real leather for luxury products such as bags, automotive interiors, and footwear without slaughtering animals.

1 investor

QR Pharma is a clinical-stage biopharmaceutical company developing buntanetap, an orally administered small molecule that inhibits the synthesis of multiple neurotoxic proteins implicated in Alzheimer's disease and Parkinson's disease. The company is conducting pivotal Phase 3 trials in early Alzheimer's disease and an open-label extension study in Parkinson's disease, with additional studies planned for Parkinson's disease dementia.

1 investor

QRX Pharma is an Australian company developing abuse-deterrent drug delivery technology for pharmaceuticals. It is currently unlisted and seeking opportunities for relisting; it was renamed Guardian Medical Solutions Limited in January 2022.

1 investor

QTSense develops quantum sensors operating at the nanoscale to detect subtle biological signals for research and diagnostic applications. The company serves academic and pharmaceutical researchers seeking earlier disease detection and improved treatment development.

1 investor

Qualterra provides molecular plant testing services for horticultural and agricultural operations, including virus screening, variety verification, and genomic analysis. The company serves growers, nurseries, and breeders seeking early pathogen detection, plant identity confirmation, and crop protection through advanced DNA/RNA testing technologies.

1 investor

QuantaMatrix is an in-vitro diagnostics company that develops rapid antimicrobial susceptibility tests to reduce treatment time for sepsis and tuberculosis. The company's core offering addresses hospitals and clinicians seeking to optimize antimicrobial therapy and combat antimicrobial resistance.

1 investor

Quarry Thera is a biotech developing oral small-molecule medicines based on induced-proximity pharmacology, using molecular glues and heterobifunctional compounds. It applies two proprietary proximity technologies (SIDTAGs and TISSTAGs) to target biology in immunology and oncology.

1 investor

Qubigen provides end-to-end AI drug design as a service, using a global federated AI system and computational workflows to generate and optimize novel drug candidates for specific protein targets. Its federated approach draws insights from clients' protected, sensitive data without moving or viewing it, serving pharmaceutical and drug discovery researchers.

1 investor

Quercis Pharma is a pharmaceutical company focused on drug discovery and development with an emphasis on making medicines accessible, affordable, and equitable globally. The company prioritizes patient outcomes and sustainable delivery of treatments across all communities.

1 investor

Quicksilver Biosciences is developing a CMOS-integrated biosensor platform that uses proprietary sensing techniques to reach higher sensitivity in a portable, lower-cost form factor. The company is currently operating in stealth mode.

1 investor

QUIITOS develops bio-inputs based on beneficial microorganisms for use in agriculture, food production, and floriculture industries. The company serves farmers and food producers with sustainable, nature-based solutions to enhance productivity and environmental health.

1 investor

Quinn is an AI research service that synthesizes biological, clinical, and competitive evidence from published literature and databases to answer drug development questions for biotech companies. It delivers structured, traceable evidence packages for decisions across target validation, indication prioritization, biomarker strategy, and trial design.

1 investor

QuitoFoods is an agritech company working on regenerative agriculture and plant genome editing ("Regenetic Engineering") to develop gene-adaptive crops, closed-loop nutrient systems, and AI-assisted distributed growing infrastructure. It connects small farming cooperatives in Latin America with synthetic biologists, climate engineers, and biotech labs, with operations spanning Ecuador and California.

1 investor

Qumir Nano develops crop protection and plant health products by combining microbial metabolites with nanostructured delivery systems to improve crop performance while reducing chemical inputs. Its technology targets agricultural challenges such as fungal disease, soil degradation and climate variability for farmers.

1 investor

Quodria develops treatments for patients with chronic skin diseases through innovative pharmaceutical solutions. The company brings together biotech experts with experience in drug discovery and late-stage clinical development.

1 investor

Quoin Pharmaceuticals is a pharmaceutical company developing therapeutic products for rare diseases, with a lead candidate, QRX003, in clinical trials for Netherton Syndrome. It plans commercial operations in the US, Western Europe, and Japan, supported by international marketing and distribution partnerships across 61 countries.

1 investor

Quotient is a biotechnology company applying somatic genetics research to R&D, developing its work through a proprietary platform. It was founded by Flagship Pioneering in collaboration with academic co-founders.

1 investor